Retreatment with pemetrexed-based chemotherapy in patients with malignant pleural mesothelioma
- 30 April 2011
- journal article
- Published by Elsevier BV in Lung Cancer
- Vol. 72 (1), 73-77
- https://doi.org/10.1016/j.lungcan.2010.12.004
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- New tricks for old biomarkers: thymidylate synthase expression as a predictor of pemetrexed activity in malignant mesotheliomaAnnals of Oncology, 2010
- Life after First-line Chemotherapy in Malignant Pleural Mesothelioma: a North-East England ExperienceClinical Oncology, 2010
- Retreatment of recurrent malignant pleural mesothelioma with cisplatin and pemetrexedInternational Journal of Clinical Oncology, 2010
- Pemetrexed Plus Cisplatin or Pemetrexed Plus Carboplatin for Chemonaïve Patients with Malignant Pleural Mesothelioma: Results of the International Expanded Access ProgramJournal of Thoracic Oncology, 2008
- Retreatment with pemetrexed-based chemotherapy in malignant pleural mesothelioma (MPM): A second line treatment optionLung Cancer, 2008
- Advances in the systemic therapy of malignant pleural mesotheliomaNature Clinical Practice Oncology, 2008
- Management of Platinum-Sensitive Recurrent Ovarian CancerSeminars in Oncology, 2006
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958